Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.2950
-0.0140 (-4.53%)
Sep 29, 2025, 12:36 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €13.83 million as of September 29, 2025. Its market cap has increased by 29.40% in one year.
Market Cap
13.83M
Enterprise Value
10.54M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.30
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 13.83M, a decrease of -86.44%. That is a compound annual growth rate of -15.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 13.83M | -53.11% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | 92.30M | -31.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 37.53B |
| UCB SA | 37.41B |
| Financière de Tubize | 7.08B |
| Fagron NV | 1.44B |
| Ion Beam Applications | 306.13M |
| Onward Medical | 221.64M |
| Hyloris Pharmaceuticals | 163.52M |
| Nyxoah | 144.13M |